NHS Greater Glasgow & Clyde Area Drug and Therapeutics Committee
Greater Glasgow and Clyde Medicines
Greater Glasgow and Clyde Medicines
For all prescribers and health professionals both in primary care and the acute sector.
All editions of PostScript (the previous name for Medicines Update) from 2011 onwards have been added to this site. Click here for an index to all previous editions. If you would like a copy of a previous edition, please contact medicines.update@ggc.scot.nhs.uk
Posted: October 23, 2017.
Category - Medicines Update
New Adult NHSGGC Guidelines now available on StaffNet
Posted: October 09, 2017.
Category - Medicines Update
Drug Safety Update (September 2017) includes: Miconazole (Daktarin): over-the-counter or...
Posted: October 09, 2017.
Category - Medicines Update
New Adult NHSGGC Guidelines now available on StaffNet
Posted: October 09, 2017.
Category - Medicines Update
Mefenamic acid is now non-formulary.Prescribers should review ongoing use and consider whether other NSAIDs may be appropriate. Ibuprofen and naproxen are the Preferred List first line options.Following consu...
Posted: October 09, 2017.
Category - Medicines Update
Patients with recurrent paroxysmal, persistent or permanent atrial fibrillation (AF) have a high risk of thromboembolism, particularly stroke. Compared to patients without AF, the absolute risk of stroke is increased almost five fold. One year ...
Posted: September 06, 2017.
Category - Medicines Update
UPDATED ALCOHOL WITHDRAWAL RECOMMENDATIONS Summary of Key Changes New Pabrinex® prescription recommendations for patients ‘at risk’ of Wernicke’s Encephalopa...
Posted: August 30, 2017.
Category - Medicines Update
Highlights the current shortage of adult hepatitis B vaccine.
Posted: August 28, 2017.
Category - Medicines Update
Drug Safety Update (August 2017) includes: Ibrutinib (Imbruvica ...
Posted: August 25, 2017.
Category - Medicines Update
The GGC Oral NSAID guideline has recently been updated. Ibuprofen and naproxen remain the NSAIDs of choice. The prescribing notes have been updated and include additional information on acute kidney injury and hepatic impairment.
Posted: August 25, 2017.
Category - Medicines Update
MST® is currently the most frequently prescribed brand of morphine sulphate modified release (M/R) across NHSGGC. From 01/09/2017 the preferred choice of solid morphine sulphate M/R across primary and secondary care will change to Zomorph® capsules.